Literature DB >> 8641975

Shortened telomere length in hepatocellular carcinomas and corresponding background liver tissues of patients infected with hepatitis virus.

K Ohashi1, M Tsutsumi, K Kobitsu, T Fukuda, T Tsujiuchi, E Okajima, S Ko, Y Nakajima, H Nakano, Y Konishi.   

Abstract

The telomere length in 20 surgically resected human hepatocellular carcinomas (HCCs) and adjacent non-cancerous livers with hepatitis virus infection were investigated. All the HCC samples examined demonstrated shorter telomere length than the corresponding non-cancerous liver tissues, the respective average values being 5.4 kbp and 8.8 kbp (P < 0.001). The shortening of telomere length was most prominent in HCCs larger than 30 mm in diameter, and in both tumors and non-cancerous livers it was more marked with hepatitis B virus as compared with hepatitis C virus infection. These results indicate that telomere shortening is associated with not only progression, but also development of HCC, and there is a possible difference in the nature of the association in patients with hepatitis viruses of B and C types.

Entities:  

Mesh:

Year:  1996        PMID: 8641975      PMCID: PMC5921122          DOI: 10.1111/j.1349-7006.1996.tb00239.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  22 in total

1.  HBx gene of hepatitis B virus induces liver cancer in transgenic mice.

Authors:  C M Kim; K Koike; I Saito; T Miyamura; G Jay
Journal:  Nature       Date:  1991-05-23       Impact factor: 49.962

2.  Significant telomere shortening in childhood leukemia.

Authors:  D J Adamson; D J King; N E Haites
Journal:  Cancer Genet Cytogenet       Date:  1992-07-15

Review 3.  Structure and function of telomeres.

Authors:  E H Blackburn
Journal:  Nature       Date:  1991-04-18       Impact factor: 49.962

4.  Restoration of telomeres in human papillomavirus-immortalized human anogenital epithelial cells.

Authors:  A J Klingelhutz; S A Barber; P P Smith; K Dyer; J K McDougall
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

5.  Genomic sequencing.

Authors:  G M Church; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

6.  Telomeres shorten during ageing of human fibroblasts.

Authors:  C B Harley; A B Futcher; C W Greider
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

7.  Telomere length predicts replicative capacity of human fibroblasts.

Authors:  R C Allsopp; H Vaziri; C Patterson; S Goldstein; E V Younglai; A B Futcher; C W Greider; C B Harley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

8.  Specific association of human telomerase activity with immortal cells and cancer.

Authors:  N W Kim; M A Piatyszek; K R Prowse; C B Harley; M D West; P L Ho; G M Coviello; W E Wright; S L Weinrich; J W Shay
Journal:  Science       Date:  1994-12-23       Impact factor: 47.728

9.  Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma.

Authors:  J Wang; X Chenivesse; B Henglein; C Bréchot
Journal:  Nature       Date:  1990-02-08       Impact factor: 49.962

10.  Length of telomeric repeats in neuroblastoma: correlation with prognosis and other biological characteristics.

Authors:  E Hiyama; K Hiyama; T Yokoyama; T Ichikawa; Y Matsuura
Journal:  Jpn J Cancer Res       Date:  1992-02
View more
  3 in total

1.  Telomere maintenance in laser capture microdissection-purified Barrett's adenocarcinoma cells and effect of telomerase inhibition in vivo.

Authors:  Masood A Shammas; Aamer Qazi; Ramesh B Batchu; Robert C Bertheau; Jason Y Y Wong; Manjula Y Rao; Madhu Prasad; Diptiman Chanda; Selvarangan Ponnazhagan; Kenneth C Anderson; Christopher P Steffes; Nikhil C Munshi; Immaculata De Vivo; David G Beer; Sergei Gryaznov; Donald W Weaver; Raj K Goyal
Journal:  Clin Cancer Res       Date:  2008-08-01       Impact factor: 12.531

2.  Telomere Length and Survival of Patients with Hepatocellular Carcinoma in the United States.

Authors:  Baiyu Yang; Fatma M Shebl; Lawrence R Sternberg; Andrew C Warner; David E Kleiner; Daniel C Edelman; Allison Gomez; Casey L Dagnall; Belynda D Hicks; Sean F Altekruse; Brenda Y Hernandez; Charles F Lynch; Paul S Meltzer; Katherine A McGlynn
Journal:  PLoS One       Date:  2016-11-23       Impact factor: 3.240

3.  Increased telomerase activities in human pancreatic duct adenocarcinomas.

Authors:  M Tsutsumi; T Tsujiuchi; O Ishikawa; T Majima; M Yoshimoto; Y Sasaki; T Fukuda; H Oohigashi; Y Konishi
Journal:  Jpn J Cancer Res       Date:  1997-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.